CTC Alternative Strategies’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

CTC Alternative Strategies’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,944	Closed	-$239K	–	193
2025 Q1	$239K	Buy	+2,944	New	+$263K	0.29%	75
2024 Q3	–	Sell	-13,000	Closed	-$1.21M	–	203
2024 Q2	$1.21M	Buy	+13,000	New	+$1.17M	0.51%	47
2023 Q3	–	Sell	-2,850	Closed	-$237K	–	199
2023 Q2	$237K	Buy	+2,850	New	+$238K	0.3%	106

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Broadwater Capital Boston, Massachusetts $134M AUM 21.11% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

CTC Alternative Strategies's XBI Position: Q2 2025 in Review

CTC Alternative Strategies sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2025, closing a stake of 2,944 shares — an estimated $239K sold.

CTC Alternative Strategies first reported a position in XBI in Q2 2023 and held it in 3 quarters. The position peaked at $1.21M in Q2 2024. 625 funds tracked by Wall St. Rank hold XBI as of Q2 2025.

CTC Alternative Strategies reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2025 after selling out during the quarter.
CTC Alternative Strategies sold 2,944 State Street SPDR S&P Biotech ETF shares in Q2 2025, an estimated $239K.
CTC Alternative Strategies first reported a position in State Street SPDR S&P Biotech ETF in Q2 2023 and held it in 3 quarters.
CTC Alternative Strategies's State Street SPDR S&P Biotech ETF position peaked at $1.21M in Q2 2024.
625 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2025.

Based on CTC Alternative Strategies's 13F filing for Q2 2025, filed 14 Aug 2025.